热门资讯> 正文

C4 Therapeutics提交价值4亿美元的混合货架产品

2025-11-22 06:15

C4 Therapeutics(CCCC) 0

C4 Therapeutics (CCCC) has filed a shelf registration to offer up to $400M in securities.
The offering may include common stock, preferred stock, debt securities, warrants, or units, in one or more combinations and tranches.

More on C4 Therapeutics

C4 Therapeutics, Inc. (CCCC) Presents at IMS Annual Meeting 2025 Oral Presentation - Slideshow
C4 Therapeutics, Inc. (CCCC) Special Call - Slideshow
C4 Therapeutics, Inc. (CCCC) Discusses On Phase 1 Trial Data Of Cemsidomide In Multiple Myeloma Presented At IMS 2025 Transcript
C4 Therapeutics prices $125M equity offering with warrants
Seeking Alpha’s Quant Rating on C4 Therapeutics

推荐文章

风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。